Previous finding that higher circulating levels of AAT in NSCLC patients correlate with worse prognosis together with our current data provide stronger evidence that in the presence of AAT cancer cells can improve their pro-tumorigenic characteristics and resistance to apoptosis. This evidence concerns the gene SERPINA1 and cancer.